As of January 22, 2025, CalAmp (CAMP) has a market cap of $0.11 billion USD. According to our data, CalAmp is ranked No.7607 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
5.36%
|
Dec 31, 2024 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Market Cap | = | CAMP Stock Price | * | CAMP Shares Outstanding |
= | $5.50 | * | 20.16 M | |
= | $0.11 B |